Journal of clinical & experimental immunology最新文献

筛选
英文 中文
Mesenchymal stem cells-derived Extracellular Vesicles: A Promising COVID-19 Therapy?” 间充质干细胞来源的细胞外囊泡:一种有希望的COVID-19治疗方法?
Journal of clinical & experimental immunology Pub Date : 2021-11-29 DOI: 10.33140/jcei.06.06.05
{"title":"Mesenchymal stem cells-derived Extracellular Vesicles: A Promising COVID-19 Therapy?”","authors":"","doi":"10.33140/jcei.06.06.05","DOIUrl":"https://doi.org/10.33140/jcei.06.06.05","url":null,"abstract":"Coronavirus disease 2019 (COVID-19) is a pandemic viral disease caused by severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2). Originated in Wuhan, China in December 2019, COVID-19 soon spread all around the world [1]. As per the WHO, till 4th August 2021, Globally, 200,174,883 confirmed cases of COVID-19, including 4,255,892 deaths and 3,984,596,440 vaccine doses have been administered [2].","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89507500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pre-Solid-Organ-Transplant COVID-19 Vaccination 固体器官移植前COVID-19疫苗接种
Journal of clinical & experimental immunology Pub Date : 2021-08-26 DOI: 10.33140/jcei.06.04.02
{"title":"Pre-Solid-Organ-Transplant COVID-19 Vaccination","authors":"","doi":"10.33140/jcei.06.04.02","DOIUrl":"https://doi.org/10.33140/jcei.06.04.02","url":null,"abstract":"Vaccine such as influenza vaccine, is administered in stable transplant recipients, although live attenuated virus vaccines are contraindicated, generally due to risk of disseminated infection [1, 2]. Neither efficacy, safety, nor durability are well known in transplant recipients due to exclusion of them from recent COVID-19 vaccine trials [1, 2]. Currently, there are no SARS-CoV-2 vaccine platforms using attenuated live virus approved in phase III trials. Nevertheless, if they are approved for use, concerns, including potential decrease in efficacy in immunocompromised patients, potential for vaccine-related allograft rejection, unknown durability of the immune response, and long-term safety data still exist. Due to experience with neither the influenza vaccine nor the adjuvant recombinant zoster vaccine having been related to allograft rejection, successful administration of influenza and adjuvanted recombinant zoster vaccines to stable transplant recipients, and unanticipated vaccine-related adverse events to the allograft having not borne out, the influenza and adjuvanted recombinant zoster vaccines are able to be extrapolated to COVID-19 vaccines [2, 3]. In immunocompromised host, concerns for adenoviral vector vaccines are focused on a viral infection, but these concerns have no scientific evidence. Although newly approved adenoviral-vector use for vaccination, this vaccine platform has been used for decades for gene therapy for cancer and other rare diseases. Inactivated virus and protein subunit vaccine platforms that have been used in transplant recipients for other infections, such as human papilloma virus, pertussis, and hepatitis A and B, are currently under investigation for SARS-CoV-2 (COVID-19) infection in transplant recipients [2].","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91276910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Clinical Study on Pancytopenia in Pregnancy in Women of Rural Haryana 哈里亚纳邦农村妇女妊娠全血细胞减少症的临床研究
Journal of clinical & experimental immunology Pub Date : 2021-06-09 DOI: 10.33140/jcei.06.03.04
{"title":"A Clinical Study on Pancytopenia in Pregnancy in Women of Rural Haryana","authors":"","doi":"10.33140/jcei.06.03.04","DOIUrl":"https://doi.org/10.33140/jcei.06.03.04","url":null,"abstract":"Pancytopenia is defined as reduction of all the three cellular elements of blood- resulting in anemia, leukopenia and thrombocytopenia. This clinical study was undertaken in a tertiary care medical college serving Gurugram district of Haryana, North India. 50 pregnant patients were found with pancytopenia, most were multigravidae, presented at term, commonest complaints being pain abdomen & leaking per vaginum, postpartum hemorrhage being the most commonly encountered complication.","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"291 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86425411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Objectivity and Practice of Peripheral Blood Smear Examination for Childhood Anemia Diagnosis in Benghazi Children Hospital /Libya 利比亚班加西儿童医院外周血涂片检查诊断儿童贫血的客观性与实践
Journal of clinical & experimental immunology Pub Date : 2021-06-09 DOI: 10.33140/jcei.06.03.03
{"title":"Objectivity and Practice of Peripheral Blood Smear Examination for Childhood Anemia Diagnosis in Benghazi Children Hospital /Libya","authors":"","doi":"10.33140/jcei.06.03.03","DOIUrl":"https://doi.org/10.33140/jcei.06.03.03","url":null,"abstract":"Introduction: Anemia is a common disease in children. Peripheral Blood Smear (PBS) require effort and human resource. In this study, we will evaluate objectivity of PBS ordering practice in Benghazi Children Hospital/Libya. Method: A retrospective study of PBS reports of 318 child in 2015 was conducted. Data collected include cause of PBS request, along with other relevant demographic, clinical and laboratory details. Kappa statistic was used for analyzing degree of agreement of results between PBS and Complete Blood Count (CBC) in anemia diagnosis. Results: Our study showed that Hematologists and 88.7% by general pediatricians requested only 6.9% of PBS. Anemia was main cause of request in 36.2%. Only 33.7 % of OPD cases referred with suspect of anemia were revealed to be anemic upon PBS examination and 45.4 % referred with no suspect of anemia were revealed to be anemic upon examination in total study population, but not in Neonate. In 65.1%, there was an agreement between diagnosis of anemia by CBC and PBS. There was accordance of 76.6% between exclusion of anemia by CBC and PBS. Hypochromic microcytic anemia was diagnosed in 93 cases (29.2%), macrocytic anemia was diagnosed in 5%, and 65.7% were not anemic. Conclusions: PBS examination is none objectively ordered and over utilized by Pediatricians in outpatient settings and for routine practice with less yield. Establishing laboratory guidelines for improving utility of PBS, careful and complete justified requests, discussion with laboratory staff, and continuous auditing practice are noticeable needs in the Benghazi Children Hospital.","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85460525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tamoxifen for Five Years 服用他莫昔芬5年
Journal of clinical & experimental immunology Pub Date : 2021-06-09 DOI: 10.33140/jcei.06.03.01
Xu Chen
{"title":"Tamoxifen for Five Years","authors":"Xu Chen","doi":"10.33140/jcei.06.03.01","DOIUrl":"https://doi.org/10.33140/jcei.06.03.01","url":null,"abstract":"Tamoxifen is an effective anti-cancer drug in breast cancer treatment. However, very few women could do the complete 5-year treatment due to the side effects of the medication. The irregular bleeding, osteoporosis, and hormonal imbalance symptoms always cut the time short. Since every woman is different in body weight, genetic compose, reproductive history, and personal habits, the treatment with tamoxifen should also be different. Moreover, since estrogen has the similar positive effects as Vitamin K2 in bone formation tamoxifen, as a estrogen blocker, should be used with proper vitamin K2 supplement, to which, current medical world has not paid enough attention.","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"93 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73384203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What Do All Autoimmune Diseases Have in Common? 所有自身免疫性疾病有什么共同之处?
Journal of clinical & experimental immunology Pub Date : 2021-06-09 DOI: 10.33140/jcei.06.03.02
{"title":"What Do All Autoimmune Diseases Have in Common?","authors":"","doi":"10.33140/jcei.06.03.02","DOIUrl":"https://doi.org/10.33140/jcei.06.03.02","url":null,"abstract":"Looking at the history of medicine, many therapies have been used, since ancient history, with the most diverse cultures, many doctors and great names were in the past but still exert great influence on our medicine.","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"22 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74349608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Red Tide: Why a Biologic, HDFx, and Magnesium Could be used to allay Inflammatory and Lung Problems Caused by Algal Blooms: Hypothesis 赤潮:为什么一种生物制剂、HDFx和镁可以用来减轻由藻华引起的炎症和肺部问题:假设
Journal of clinical & experimental immunology Pub Date : 2021-01-21 DOI: 10.33140/jcei.06.01.03
{"title":"Red Tide: Why a Biologic, HDFx, and Magnesium Could be used to allay Inflammatory and Lung Problems Caused by Algal Blooms: Hypothesis","authors":"","doi":"10.33140/jcei.06.01.03","DOIUrl":"https://doi.org/10.33140/jcei.06.01.03","url":null,"abstract":"Over the past decade, there has been a growing concern over invasion of Florida Gulf Coastal Waters and beaches by several algal blooms created by “red tides”. These algal blooms create various toxins that pose high risks for marine life, livestock, birds, and humans [1, 2]. The algae become so numerous that they discolor gulf waters and beaches. Since the 1980’s, red tides have been seen in many countries throughout the globe (i.e., South America, Central America, Japan, caribbean, South Pacific regions, etc.).","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85998997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
What we learned from the Covid-19 Outbreak in 2020 我们从2020年的Covid-19疫情中学到了什么
Journal of clinical & experimental immunology Pub Date : 2021-01-21 DOI: 10.33140/jcei.06.01.02
{"title":"What we learned from the Covid-19 Outbreak in 2020","authors":"","doi":"10.33140/jcei.06.01.02","DOIUrl":"https://doi.org/10.33140/jcei.06.01.02","url":null,"abstract":"The onset of worldwide contamination of an unknown subject brought a lot of fear around the world. The first thought was that reducing of interpersonal distance and reduction of travelling would undermine contamination. Rather quickly the origin of the evil in the form of a Covid-19 virus became clearer after energetic investigation in only several weeks. Rapidly it has been decided that a vaccination would be helpful to attack the problem.","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"20 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75652936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytokines: The Game Changer in Pathogenesis of Covid-19 细胞因子:改变Covid-19发病机制的游戏规则
Journal of clinical & experimental immunology Pub Date : 2021-01-21 DOI: 10.33140/jcei.06.01.01
{"title":"Cytokines: The Game Changer in Pathogenesis of Covid-19","authors":"","doi":"10.33140/jcei.06.01.01","DOIUrl":"https://doi.org/10.33140/jcei.06.01.01","url":null,"abstract":"A small particle of the size about 100 micrometers (SARS-V2) has shaken the world. In some Covid-19 patients a severe immune reaction was found in which cells release too many cytokines into the blood too quickly. Cytokines are regulators of host responses to infection, immune responses, inflammation, and trauma. In addition, cytokines activate those cells, stimulating them to produce more cytokines. Normally, this feedback loop is kept in check by the body. Some cytokines act to make disease worse. Cytokine storms might explain why some people have a severe reaction to corona viruses while others only experience mild symptoms. They could also be the reason why younger people are less affected, as their immune systems are less developed and so produce lower levels of inflammation-driving cytokines. Since, in early 2020, Covid -19 became pandemic, globally multi-pronged research started to get rid of corona virus 2 (SARSCoV-2) [1, 2]. For such a task, it was necessary to understand the pathogenesis of covid-19, due to the fact that SARS-CoV-2, is new and its mechanism of action and its interrelationship with the human body organs is not fully known yet. Nevertheless, it is known that all viruses and bacteria when invade the body interact with the immune system, inflammation starts and if the immune system cannot get rid of the invaders, pathogenesis starts.","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"13 42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80561045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
COVID-19 Perceptional Disparity Among Dental Practitioners in Tricity (Chandigarh, Panchkula and Mohali) 三邦(昌迪加尔、潘切库拉和莫哈里)牙医对COVID-19的认知差异
Journal of clinical & experimental immunology Pub Date : 2021-01-21 DOI: 10.33140/jcei.06.01.04
{"title":"COVID-19 Perceptional Disparity Among Dental Practitioners in Tricity (Chandigarh, Panchkula and Mohali)","authors":"","doi":"10.33140/jcei.06.01.04","DOIUrl":"https://doi.org/10.33140/jcei.06.01.04","url":null,"abstract":"Background: Coronavirus (SARS-CoV-2) made the headlines after its initial breakout in Wahan, China in December 2019. Viral by genome, lethal by nature, strongly contagious by character succeeded in making a new chapter in everyone’s life in a very short span making it a pandemic Objectives: The aim of this study was to assess perceptional disparity among dental practitioners regarding the Coronavirus Disease 2019 (COVID-2019) pandemic. Material and methods: A total of 300 participating dentists were randomly included in this cross sectional survey. A self structured, closed ended questionnaire was administered to each participant to record demographic and professional characteristics followed by their knowledge regarding corona virus. Statistical analysis was performed using SPSS Version 20 and Multivariable linear regression analysis was carried out Results: It was found that only 33.3% of the clinicians had high knowledge regarding corona virus and only 38.5% of the respondents know the correct incubation period. About 65 % of the practitioners did not know about the diagnostic test available for corona virus and only 4.3 % of them gained knowledge rom journals or print media The above responses indicate a low knowledge among the dental practitioners regarding corona virus. Conclusions: The knowledge and practice scores were found to be worrisome, which is important to combat COVID-19. They are advised to follow the Centers of Disease Control and Prevention (CDC) and World Health Organization (WHO) guidelines in their clinics, and sensitize their staff so that no stone is left unturned in defeating this pandemic.","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90711603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书